For the Inventor, By the Inventor

Enter assignee name

Vancouver, Canada

Stemcell Technologies Canada Inc.

USPTO Granted Patents = 14

EPO Patents = 4

Trademarks = 62

Forward Citations = 1

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Armon R Sharei (4 out of 18 patents)

Maisam Dadgar (4 out of 9 patents)

Howard Bernstein (3 out of 65 patents)

4. Eric Jervis (3 out of 6 patents)

5. Scott Loughhead (2 out of 3 patents)

6. Emanuel Nazareth (2 out of 2 patents)

7. Martin O'keane (2 out of 2 patents)

8. Tarek Abdeljawad (2 out of 2 patents)

9. Charis-Patricia Segeritz (2 out of 2 patents)

10. Ryan Conder (2 out of 2 patents)

11. Michael Riedel (2 out of 2 patents)

12. Jacquelyn L Sikora Hanson (2 out of 2 patents)

13. Andy Isamu Kokaji (1 out of 6 patents)

14. Jonathan B Gilbert (1 out of 2 patents)

15. Matthew Booty (1 out of 2 patents)

14 patents: Sort by Forward Citations

1. 12497581 - High-throughput microfluidic chip having parallelized constrictions for perturbing cell membranes (2025-12-16),

2. 12385001 - Systems, methods and apparatus for the automated culture of cells (2025-08-12),

3. 12383904 - Device for manipulating samples (2025-08-12),

4. 12370222 - Compositions and methods for obtaining organoids (2025-07-29),

5. 12351825 - Soluble antibody complexes for T cell or NK cell activation and expansion (2025-07-08),

6. 12312576 - System for delivery of a payload into a cell (2025-05-27),

7. 12276658 - Compositions and methods for rapid and reversible biomolecular labeling (2025-04-14),

8. 12258552 - Systems, methods and apparatus for adaptive passage of a culture of cells (2025-03-25),

9. 12201652 - Intracellular delivery of biomolecules to induce tolerance (2025-01-21),

10. 12150982 - Formulations of PBMCs (2024-11-26),

11. 12029764 - Compositions and methods for obtaining organoids (2024-07-09),

12. 12018240 - High-throughput microfluidic chip having parallelized constrictions for perturbing cell membranes (2024-06-25),

13. 11725042 - Methods and devices for complexing target entities (2023-08-15),

14. 11697796 - Media and methods for enhancing the survival and proliferation of stem cells (2023-07-11),

Stemcell Technologies Canada Inc. is a global biotechnology company that specializes in developing cell culture media, cell separation products, and ancillary reagents for life science research. With a focus on providing innovative and high-quality tools for scientists, Stemcell Technologies has become a trusted partner for researchers in the field of stem cell biology and regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

14 Patents

#59 in Vancouver

#1,015 in Canada

#40,903 in the World

Vancouver, Canada

Stemcell Technologies Canada Inc.

Forward Citations = 1

31 inventors:

Armon R Sharei (4 out of 18 patents)

Maisam Dadgar (4 out of 9 patents)

Howard Bernstein (3 out of 65 patents)

4. Eric Jervis (3 out of 6 patents)

5. Scott Loughhead (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…